-
1
-
-
34247612824
-
In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: Illustration of intraluminal supersaturation
-
Brouwers J, Tack J, and Augustijns P (2007) In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation. Int J Pharm 336:302-309.
-
(2007)
Int J Pharm
, vol.336
, pp. 302-309
-
-
Brouwers, J.1
Tack, J.2
Augustijns, P.3
-
2
-
-
0034807802
-
Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate
-
Cummins CL, Mangravite LM, and Benet LZ (2001) Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm Res 18:1102-1109.
-
(2001)
Pharm Res
, vol.18
, pp. 1102-1109
-
-
Cummins, C.L.1
Mangravite, L.M.2
Benet, L.Z.3
-
3
-
-
0037677559
-
P-glycoprotein attenuating effect of human intestinal fluid
-
Deferme S, Tack J, Lammert F, and Augustijns P (2003) P-glycoprotein attenuating effect of human intestinal fluid. Pharm Res 20:900-903.
-
(2003)
Pharm Res
, vol.20
, pp. 900-903
-
-
Deferme, S.1
Tack, J.2
Lammert, F.3
Augustijns, P.4
-
4
-
-
56149087140
-
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories
-
Hayeshi R, Hilgendorf C, Artursson P, Augustijns P, Brodin B, Dehertogh P, Fisher K, Fossati L, Hovenkamp E, Korjamo T, et al. (2008) Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci 35:383-396.
-
(2008)
Eur J Pharm Sci
, vol.35
, pp. 383-396
-
-
Hayeshi, R.1
Hilgendorf, C.2
Artursson, P.3
Augustijns, P.4
Brodin, B.5
Dehertogh, P.6
Fisher, K.7
Fossati, L.8
Hovenkamp, E.9
Korjamo, T.10
-
5
-
-
70449440262
-
How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials
-
Hill A, van der Lugt J, Sawyer W, and Boffito M (2009) How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials. AIDS 23:2237-2245.
-
(2009)
AIDS
, vol.23
, pp. 2237-2245
-
-
Hill, A.1
Van Der Lugt, J.2
Sawyer, W.3
Boffito, M.4
-
6
-
-
77956008536
-
In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal P-glycoprotein by ritonavir causing increased darunavir absorption
-
Holmstock N, Mols R, Annaert P, and Augustijns P (2010) In situ intestinal perfusion in knockout mice demonstrates inhibition of intestinal P-glycoprotein by ritonavir causing increased darunavir absorption. Drug Metab Dispos 38:1407-1410.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 1407-1410
-
-
Holmstock, N.1
Mols, R.2
Annaert, P.3
Augustijns, P.4
-
7
-
-
79959359682
-
Ritonavir-boosted protease inhibitors in HIV therapy
-
Hull MW and Montaner JS (2011) Ritonavir-boosted protease inhibitors in HIV therapy. Ann Med 43:375-388.
-
(2011)
Ann Med
, vol.43
, pp. 375-388
-
-
Hull, M.W.1
Montaner, J.S.2
-
8
-
-
1842557505
-
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
-
Ingels F, Beck B, Oth M, and Augustijns P (2004) Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers. Int J Pharm 274:221-232.
-
(2004)
Int J Pharm
, vol.274
, pp. 221-232
-
-
Ingels, F.1
Beck, B.2
Oth, M.3
Augustijns, P.4
-
9
-
-
72749106653
-
The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters
-
Kis O, Robillard K, Chan GN, and Bendayan R (2010) The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci 31:22-35.
-
(2010)
Trends Pharmacol Sci
, vol.31
, pp. 22-35
-
-
Kis, O.1
Robillard, K.2
Chan, G.N.3
Bendayan, R.4
-
11
-
-
67650084777
-
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs
-
Matsson P, Pedersen JM, Norinder U, Bergström CA, and Artursson P (2009) Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res 26:1816-1831.
-
(2009)
Pharm Res
, vol.26
, pp. 1816-1831
-
-
Matsson, P.1
Pedersen, J.M.2
Norinder, U.3
Bergström, C.A.4
Artursson, P.5
-
12
-
-
0034812580
-
Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures
-
Mohri K and Uesawa Y (2001) Enzymatic activities in the microsomes prepared from rat small intestinal epithelial cells by differential procedures. Pharm Res 18:1232-1236.
-
(2001)
Pharm Res
, vol.18
, pp. 1232-1236
-
-
Mohri, K.1
Uesawa, Y.2
-
13
-
-
66649103351
-
Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: Evaluation of a novel tool in biopharmaceutical drug profiling
-
Mols R, Brouwers J, Schinkel AH, Annaert P, and Augustijns P (2009) Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: evaluation of a novel tool in biopharmaceutical drug profiling. Drug Metab Dispos 37:1334-1337.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1334-1337
-
-
Mols, R.1
Brouwers, J.2
Schinkel, A.H.3
Annaert, P.4
Augustijns, P.5
-
14
-
-
0034932521
-
Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man
-
Salphati L, Childers K, Pan L, Tsutsui K, and Takahashi L (2001) Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. J Pharm Pharmacol 53:1007-1013.
-
(2001)
J Pharm Pharmacol
, vol.53
, pp. 1007-1013
-
-
Salphati, L.1
Childers, K.2
Pan, L.3
Tsutsui, K.4
Takahashi, L.5
-
15
-
-
78649885201
-
Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir
-
Sevrioukova IF and Poulos TL (2010) Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir. Proc Natl Acad Sci USA 107:18422-18427.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 18422-18427
-
-
Sevrioukova, I.F.1
Poulos, T.L.2
-
16
-
-
34047178340
-
Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein
-
Storch CH, Theile D, Lindenmaier H, Haefeli WE, and Weiss J (2007) Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein. Biochem Pharmacol 73:1573-1581.
-
(2007)
Biochem Pharmacol
, vol.73
, pp. 1573-1581
-
-
Storch, C.H.1
Theile, D.2
Lindenmaier, H.3
Haefeli, W.E.4
Weiss, J.5
-
17
-
-
79953686193
-
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
-
Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, and Terasaki T (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333-345.
-
(2011)
J Neurochem
, vol.117
, pp. 333-345
-
-
Uchida, Y.1
Ohtsuki, S.2
Katsukura, Y.3
Ikeda, C.4
Suzuki, T.5
Kamiie, J.6
Terasaki, T.7
-
18
-
-
63849123835
-
Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects
-
Vermeir M, Lachau-Durand S, Mannens G, Cuyckens F, van Hoof B, and Raoof A (2009) Absorption, metabolism, and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects. Drug Metab Dispos 37:809-820.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 809-820
-
-
Vermeir, M.1
Lachau-Durand, S.2
Mannens, G.3
Cuyckens, F.4
Van Hoof, B.5
Raoof, A.6
-
19
-
-
1842576537
-
Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects
-
Vertzoni M, Fotaki N, Kostewicz E, Stippler E, Leuner C, Nicolaides E, Dressman J, and Reppas C (2004) Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. J Pharm Pharmacol 56:453-462.
-
(2004)
J Pharm Pharmacol
, vol.56
, pp. 453-462
-
-
Vertzoni, M.1
Fotaki, N.2
Kostewicz, E.3
Stippler, E.4
Leuner, C.5
Nicolaides, E.6
Dressman, J.7
Reppas, C.8
-
20
-
-
0346025675
-
Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
-
Zeldin RK and Petruschke RA (2004) Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother 53:4-9.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 4-9
-
-
Zeldin, R.K.1
Petruschke, R.A.2
|